Mont Pharmaceuticals Private Limited
About Mont Pharmaceuticals Private Limited
Data last updated:
Mont Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 18 October 2024.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U47721DL2024PTC437901.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Akshay Raj Saxena and Sunil Kumar Saxena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 49B, Block – D Shakarpur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹64,828. For the same year it recorded a net loss of ₹1.1 Lakh (net margin -169.7%) and EBITDA of -₹1.08 Lakh (EBITDA margin -166.1%).
Company details
Contact details
Mont Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressD – 49B, Block – D Shakarpur, New Delhi, Delhi, India – 110092
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mont Pharmaceuticals Private Limited
FY 2025 filings availableMont Pharmaceuticals Private Limited reported revenue of ₹64,828 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹1.08 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹1.1 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -166.1% |
| Net Profit Margin | -169.7% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Mont Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mont Pharmaceuticals Private Limited
Mont Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshay Raj Saxena | Director | 18 Oct 2024 | 2 Years 0 Months | Current |
| Sunil Kumar Saxena | Director | 18 Oct 2024 | 2 Years 0 Months | Current |
Peer comparison
Mont Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Truvida Pharmaceuticals Private Limited | ₹66,451 (FY 2024) | Hyderabad, Telangana, India | ||||
| Prarthana Pharmaceuticals Private Limited | ₹66,013 (FY 2025) | -93.0% | Gaya, Bihar, India | |||
| Aarudhra Pharmaceuticals Private Limited | ₹66,000 (FY 2022) | Tirupur, Tamil Nadu, India | ||||
| Nervet Pharmaceuticals Private Limited | ₹65,820 (FY 2024) | Haridwar, Uttarakhand, India | ||||
| Mclaren Pharmaceuticals Private Limited | ₹65,568 (FY 2015) | Mandideep, Madhya Pradesh, India | ||||
| Mont Pharmaceuticals Private Limitedthis company | ₹64,828 (FY 2025) | -₹1.1 Lakh | -169.7% | New Delhi, Delhi, India | ||
| Expergen Pharmaceuticals Private Limited | ₹63,630 (FY 2020) | 10.0% | Andheri East Mumbai, Maharashtra, India | |||
| Magisca Pharmaceuticals Private Limited | ₹63,622 (FY 2025) | -33.0% | New Delhi, Delhi, India | |||
| Pushkar Pharmaceuticals Pvt Ltd | ₹63,000 (FY 2024) | 23.0% | Chandigarh, India | |||
| Mankem Pharmaceuticals Private Limited | ₹62,976 (FY 2025) | -20.0% | Jehanabad, Bihar, India | |||
| Lasis Pharmaceuticals Private Limited | ₹62,451 (FY 2025) | 217.0% | Darbhanga, Bihar, India |
To see the full peer comparison of Mont Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mont Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mont Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mont Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mont Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Akshay Raj Saxena was appointed as Director on 18 Oct 2024.
Frequently asked questions
Mont Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 18 October 2024 (2+ years old) and is registered under CIN U47721DL2024PTC437901.
Mont Pharmaceuticals has 2 current directors:
- Akshay Raj Saxena - Director
- Sunil Kumar Saxena - Director
The latest financial statements of Mont Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Mont Pharmaceuticals is U47721DL2024PTC437901. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mont Pharmaceuticals was incorporated on 18 October 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mont Pharmaceuticals by revenue are Truvida Pharmaceuticals Private Limited, Prarthana Pharmaceuticals Private Limited, Aarudhra Pharmaceuticals Private Limited, Nervet Pharmaceuticals Private Limited, Mclaren Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Akshay Raj Saxena was appointed as Director on 18 Oct 2024. Sunil Kumar Saxena was appointed as Director on 18 Oct 2024.
The registered office of Mont Pharmaceuticals is at D – 49B, Block – D Shakarpur, New Delhi, Delhi, India – 110092.
Mont Pharmaceuticals can be reached at its registered office: D – 49B, Block – D Shakarpur, New Delhi, Delhi, India – 110092.
Mont Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
